Phase II study of bortezomib with cisplatin as first-line treatment of malignant pleural mesothelioma (MPM): EORTC 08052.
Mary O'Brien
No relevant relationships to disclose
Rabab Mohamed Gaafar
No relevant relationships to disclose
Sanjaykumar Popat
No relevant relationships to disclose
Francesco Grossi
No relevant relationships to disclose
Allan Price
No relevant relationships to disclose
Denis Charles Talbot
No relevant relationships to disclose
Tanja Cufer
No relevant relationships to disclose
Christian H.H Ottensmeier
No relevant relationships to disclose
Sarah Danson
No relevant relationships to disclose
Athanasios G. Pallis
No relevant relationships to disclose
Baktiar Hasan
No relevant relationships to disclose
Jan P. Van Meerbeeck
No relevant relationships to disclose
Paul Baas
No relevant relationships to disclose